Summary
Updated Aug 30, 2026
Simcere Zaiming, Inc. files SEC Form 4 reports at NextCure, Inc. (NXTC). 1 SEC Form 4 filing on record, dated 12 August 2026. Most recent open-market trade: sold $185K of NXTC on 12 August 2026. Lifetime open-market sales: $185K.
Recent Transactions
1Every recent SEC Form 4 transaction Simcere Zaiming, Inc. has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Simcere Zaiming, Inc. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ADAR1 Capital Management, LLC - $1.71M of NXTC open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is Simcere Zaiming, Inc.?
Simcere Zaiming, Inc. is a corporate entity of NextCure, Inc. (NXTC). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Simcere Zaiming, Inc. submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Simcere Zaiming, Inc. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($185K) across all tracked filings.
Where can I see all of Simcere Zaiming, Inc.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Simcere Zaiming, Inc. and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
